Everyone

CTF Developer Pancza

Nougat

The Neurofibromatosis (NF) Conference is recognized as the premier annual scholarly gathering of almost 500 international (NF) researchers, clinicians, patient advocates, industry and government representatives. NF type 1, NF type 2 and Schwannomatosis are rare neurogenetic syndromes that result in significant morbidity and mortality, that are caused by genetic mutations implicated in many common diseases. Recent discoveries have shown that many malignant cancers such as breast, brain and lung cancers show hot spot mutations in the NF genes, which has significantly increased the larger cancer community’s appetite in understanding neurofibromatosis.
The 2-day virtual event is sponsored by the Children’s Tumor Foundation, organized along with thought leaders in the fields of neurofibromatosis. This year’s conference is suitably formatted as a virtual event, and will focus its attention on submitted abstracts highlighting the latest in cutting edge research, and integration of basic science discovery, translational data and outcomes from clinical trials in a meaningful way to both enhance the quality of ongoing research and improve current clinical care.

The annual NF Conference is hosted and sponsored by the Children’s Tumor Foundation, a non-profit 501( c) (3) medical foundation dedicated to improving the health and well-being of individuals and families affected by the neurofibromatosis (NF). The mission of the Children’s Tumor Foundation is to: Drive research, expand knowledge, and advance care for the NF community.

Our Vision: End NF


CTF NF Conference

Latest Version of CTF NF Conference